Antibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN252546 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tumor Necrosis Factor (Ligand) Superfamily, Member 11 (TNFSF11) (AA 1-317) antibody
- Antibody type
- Monoclonal
- Description
- Protein G purified
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Epitope
- AA 1-317
- Isotype
- IgG
- Antibody clone number
- 12A668
- Vial size
- 0.1 mg
- Storage
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer.
The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia.
Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol.
Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone.
Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis.
Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.
Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines.
Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors.
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.
Hu P, Chu GC, Zhu G, Yang H, Luthringer D, Prins G, Habib F, Wang Y, Wang R, Chung LW, Zhau HE
PloS one 2011;6(12):e28670
PloS one 2011;6(12):e28670
The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
Shin M, Matsuo K, Tada T, Fukushima H, Furuta H, Ozeki S, Kadowaki T, Yamamoto K, Okamoto M, Jimi E
Carcinogenesis 2011 Nov;32(11):1634-40
Carcinogenesis 2011 Nov;32(11):1634-40
Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia.
Parrula C, Zimmerman B, Nadella P, Shu S, Rosol T, Fernandez S, Lairmore M, Niewiesk S
Veterinary pathology 2009 Sep;46(5):1003-14
Veterinary pathology 2009 Sep;46(5):1003-14
Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol.
Ghoreishi M, Bach P, Obst J, Komba M, Fleet JC, Dutz JP
Journal of immunology (Baltimore, Md. : 1950) 2009 May 15;182(10):6071-8
Journal of immunology (Baltimore, Md. : 1950) 2009 May 15;182(10):6071-8
Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone.
Sandra F, Hendarmin L, Kukita T, Nakao Y, Nakamura N, Nakamura S
Oral oncology 2005 Jul;41(6):637-44
Oral oncology 2005 Jul;41(6):637-44
Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis.
Rubin J, Chung LW, Fan X, Zhu L, Murphy TC, Nanes MS, Rosen CJ
The Prostate 2004 Jan 1;58(1):41-9
The Prostate 2004 Jan 1;58(1):41-9
Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression.
Pearse RN, Sordillo EM, Yaccoby S, Wong BR, Liau DF, Colman N, Michaeli J, Epstein J, Choi Y
Proceedings of the National Academy of Sciences of the United States of America 2001 Sep 25;98(20):11581-6
Proceedings of the National Academy of Sciences of the United States of America 2001 Sep 25;98(20):11581-6
Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines.
Fiumara P, Snell V, Li Y, Mukhopadhyay A, Younes M, Gillenwater AM, Cabanillas F, Aggarwal BB, Younes A
Blood 2001 Nov 1;98(9):2784-90
Blood 2001 Nov 1;98(9):2784-90
Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors.
Kikuchi T, Matsuguchi T, Tsuboi N, Mitani A, Tanaka S, Matsuoka M, Yamamoto G, Hishikawa T, Noguchi T, Yoshikai Y
Journal of immunology (Baltimore, Md. : 1950) 2001 Mar 1;166(5):3574-9
Journal of immunology (Baltimore, Md. : 1950) 2001 Mar 1;166(5):3574-9
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.
Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ
Proceedings of the National Academy of Sciences of the United States of America 1999 Mar 30;96(7):3540-5
Proceedings of the National Academy of Sciences of the United States of America 1999 Mar 30;96(7):3540-5
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC